Publications in the NUM

Gebel C, Kloppenburg L, Jansky MK, Nauck F, Schade F, Weddin U. „Es waren Kreativität und Umdenken erforderlich.“ Auswirkungen der COVID-19 Pandemie auf die spezialisierte ambulante Palliativversorgung (SAPV). Eine bundesweite Onlinebefragung. Gesundheitswesen. 2021;      [DOI] 

Reichardt M, Moller Jensen P, Andersen Dahl V, Bjorholm Dahl A, Ackermann M, Shah H, Länger F, Werlein C, Kuehnel MP, Jonigk D, Salditt T. 3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography. eLife. 2021 Dec.; 10e71359.      [DOI]      [File] 

Reichardt M, Moller Jensen P, et al . 3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography. Elife. 2021; 10e71359.      [DOI] 

Vesper N, et al . A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants. Frontiers in immunology. 2021; 12      [DOI] 

Iftekhar EN, Priesemann V, Balling R, Bauer S, Beutels P, Valdez AC, Cuschieri S, Czypionla T, Dumpis U, Glaab E, Grill E, Hanson C, Hotulainen P, Klimek P, Kretzschmar M, Krüger T, Krutzinna J, Low N, Machado H, Martins C, McKee M, Mohr SB, Nassehi A, Perc M, Petelos E, Pickersgrill M, Prainsack B, Rocklöv J, Schernhammer E, Staines A, Szczurek E, Tsiodras S, Van Gucht S, Willeit P. A look into the future of the COVID-19 pandemic in Europe: an expert consultation. The Lancet Regional Health-Europe. 2021; 8100185.      [DOI] 

Wang Z, Cryar A, Lemke O, Ludwig D, Tober-Lau P, Helbig ea. A multiplex protein panel assay determines disease severity and is prognostic about outcome in COVID-19 patients. medRxiv. 2021;      [DOI] 

Mahoney M, et al . A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Proceedings of the National Academy of Sciences of the United States of America. 2021; 118      [DOI] 

Peter AS, et al . A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model. European journal of immunology. 2021;      [DOI] 

Peter AS, Roth E, Schulz S, et al . A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model. Eur J Immunol. 2021;      [DOI]      [File] 

Schuh W, et al . A surrogate cell-based SARS-CoV-2 spike blocking assay. European journal of immunology. 2021;      [DOI] 

Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, Röhl A, Freiwald A, Szyrwiel L, Ludwig D, Stahl D. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021; 12(8):780—794.e7.      [DOI] 

Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell ea. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021; 12780—+.

Demichev V, et al . A time-resolved proteomic and prognostic map of COVID-19. Cell Systems. 2021;      [DOI] 

Brümmer L, Katzenschlager S, Gaeddert M, Stahl D. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLOS Medicine. 2021; 18(8):      [DOI]      [File] 

Stanifer ML, Boulant S. Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 (BSL-3) Conditions. JoVE. 2021; (166):e62857.      [DOI] 

Mürbe D, Kriegel M, Lange J, et al . Aerosol emission in professional singing of classical music. Sci Rep. 2021; 11      [DOI] 

Mürbe D, Kriegel M, Lange J, et al . Aerosol emission of adolescents voices during speaking, singing and shouting. PLoS ONE. 2021; 16(2):      [DOI] 

Schwartz J, Reuters MC, Schallenburger M, Stahl D. Allgemeine Palliativversorgung in Pandemiezeiten. Onkologe. 2021; 27686-690.      [DOI] 

Weber J, Tielker JM, Kamandi N, et al . Ambulante Betreuung onkologischer Patienten in palliativer Behandlungssituation und ihrer Angehörigen in der COVID-19-Pandemie. Onkologe. 2021; 27783-789.      [DOI] 

Priesemann V, Balling R, Brinkmann MM, Ciesek S, Czypionka T, Eckerle I, Giordano G, Hanson C, Hel Z, Hotulainen P, Klimek P, Nassehi A, Peichl A, Perc M, Petelos E, Prainsack B, Szczurek E. An action plan for pan-European defence against new SARS-CoV-2 variants. The Lancet. 2021; 397(10273):469—470.      [DOI] 

Bagheri G, Thiede B, Hejazi B, et al . An upper bound on one-to-one exposure to infectious human respiratory particles. PNAS. 2021; 118(49):      [DOI] 

Schulze J, Mache C, Balazs A, Frey D, Niemeyer D, Olze ea. Analysis of SARS-CoV-2 replication in explant cultures of the human upper respiratory tract reveals broad tissue tropism of wild-type and B.1.1.7 variant viruses. J Infect Dis. 2021;      [DOI] 

Renn M, Bartok E, Zillinger T, Hartmann G, Behrendt R. Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions. Pharmacology & Therapeutics. 2021; 107931.      [DOI] 

Gagiannis D, Umathum VG, Bloch W, Rother C, Stahl M, Witte HM, Djudjaj S, Boor P, Steinestel K. Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2. Am J Clin Pathol. 2021;      [DOI] 

Nikolai O, Rohardt C, Tobian F, et al . Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter?. Infect Dis. 2021; 53(12):      [DOI]      [File] 

Popp M, Stegemann M, Riemer M, Metzendorf M, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Antibiotics for the treatment of COVID‐19. Cochrane Database of Systematic Reviews. 2021; 2021CD015025.      [DOI] 

Althaus K, Marini I, Zlamal J, Pelzl L, Singh A, Häberle H, Mehrländer M, Hammer S, Schulze H, Bitzer M, Malek N, Rath D, Bösmüller H, Nieswandt B, Gawaz M, Bakchoul T, Rosenberger P. Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. 2021 Feb.; 137(8):1061—1071.      [DOI]      [File] 

Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller JA, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica. 2021 May; 106(8):2170—2179.      [DOI]      [File] 

Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller J, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica. 2021 Aug.; 106(8):2170-2179.      [DOI] 

Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel H, Büttnerova I, Elezkurtaj S, Scheibe F, Radke J, Meisel C, Drosten C, Radbruch H, Heppner F, Corman V, Stenzel W. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol. 2021 Aug.; 78(8):948-960.      [DOI] 

Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel ea. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol. 2021; 78948—960.

Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel H, Büttnerova I, Elezkurtaj S, Scheibe F, Radke J, Meisel C, Drosten C, Radbruch H, Heppner FL, Corman VM, Stenzel W. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurology. 2021 Aug.; 78(8):948—960.      [DOI]      [File] 

Pogarell O, Pröbstl L, Rüb M, Wiegand H, Tüscher O, Lieb K, Wassiliwizky E, Gerlinger G, Heinz A, Falkai P. Auswirkungen der COVID-19-Pandemie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland. Der Nervenarzt. 2021; 92(6):562—570.      [DOI] 

Klüpfel J, Koros RC, Dehne K, et al . Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA). Anal Bioanal Chem. 2021; 413(22):      [DOI] 

Evert K, Dienemann T, Brochhausen C, Lunz D, Lubnow M, Ritzka M, Keil F, Trummer M, Scheiter A, Salzberger B, Stahl D. Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Arch. 2021; 1-12.      [DOI] 

Evert K, Dienemann T, Brochhausen C, Lunz D, Lubnow M, Ritzka M, Keil F, Trummer M, Scheiter A, Salzberger B, Reischl U, Boor P, Gessner A, Jantsch J, Calvisi DF, Evert M, Schmidt B, Simon M. Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Archiv. 2021 Jul.; 479(1):97—108.      [DOI]      [File] 

Ihlow J, Michaelis E, Greuel S, Heynol V, Lehmann A, Radbruch H, Meinhardt J, Miller F, Herbst H, Corman VM, Westermann J, Bullinger L, Horst D, Brünneck A, Elezkurtaj S. B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased. International Journal of Infectious Diseases. 2021 Feb.; 103628—635.      [DOI]      [File] 

Arora P, et al . B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination. Cell Reports. 2021; 109825.      [DOI] 

Bartenschlager C, Römmele C, Temizel S. Befragung zum Besuchsmanagement: Wie Pflegeeinrichtungen Besuche während der COVID-19-Pandemie organisierten. Protzenziale digitaler Systeme kaum genutzt. CAREkonkret. 2021; 32/33     [File] 

Kumar S, Çalışkan D, Janowski J, Faist A, Conrad B, Lange ea. Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics. Front Immunol. 2021; 12752227.

Traxler S, Schindler M, Bösmüller H, Klingel K. Biologie und Pathologie von Coronaviren. Der Pathologe. 2021 Mar.; 42(2):149—154.      [DOI]      [File] 

Traxler S, Schindler M, Bösmüller H, Klingel K. Biologie und Pathologie von Coronaviren [Biology and pathology of coronaviruses]. Pathologe. 2021; 42(2):149-154.

Swoboda J, Wittschieber D, Sanft J, Kleemann S, Elschner S, Ihle H, Hubig M, Pletz MW, Mall G, Gaßler N. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2. Histopathology. 2021 Apr.; 78(5):727—737.      [DOI]      [File] 

Swoboda J, Wittschieber D, Sanft J, Kleemann S, Elschner S, Ihle H, Hubig M, Pletz M, Mall G, Gassler N. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2. Histopathology. 2021 Apr.; 78(5):727-737.      [DOI] 

Burns J, Movsisyan A, Rehfuess E, Stratil J. Border control and SARS-CoV-2: an opportunity for generating highly policy-relevant, real-world evidence. Journal of Travel Medicine. 2021; 1—3.      [DOI] 

Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, Giordano G, Hanson C, Hens N, Iftekhar E, Klimek P, Kretzschmar M, Peichl A, Perc M, Sannino F, Schernhammer E, Schmidt A, Staines A, Szczurek E. Call for a pan-European COVID-19 response must be comprehensive – Authors‘ reply. The Lancet. 2021; 397(10284):1541.      [DOI] 

Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, Giordano G, Gurdasani D, Hanson C, Hens N, Iftekhar E, Kelly-Irving M, Klimek P, Kretzschmar M, Peichl A, Perc M, Sannino F, Schernhammer E, Schmidt A, Staines A, Szczurek E. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. The Lancet. 2021; 397(10269):92—93.      [DOI] 

Bräuninger H, Stoffers B, Fitzek A, et al . Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart. Cardiovasc Res. 2021; cvab322.      [DOI] 

Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, Kunze CA, Sinn BV, Gerhold M, Hauptmann K, Ingold-Heppner B, Miller F, Herbst H, Corman VM, Martin H, Radbruch H, Heppner FL, Horst D. Causes of death and comorbidities in hospitalized patients with COVID-19. Scientific Reports. 2021 Feb.; 11(1):4263.      [DOI]      [File] 

Doehn J, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, Gabriel F, Kurth F, Meisel C, Corman V, Stahl D. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021; 49(4):757—762.      [DOI]